MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 106 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,901 | -61.9% | 10,671 | -48.6% | 0.00% | – |
| Q2 2023 | $225,530 | +10375.2% | 20,767 | +6556.1% | 0.00% | – |
| Q1 2023 | $2,153 | +82.8% | 312 | +5.4% | 0.00% | – |
| Q4 2022 | $1,178 | +17.8% | 296 | +31.6% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 225 | +1.8% | 0.00% | – |
| Q2 2022 | $1,000 | -97.8% | 221 | -95.5% | 0.00% | – |
| Q1 2022 | $46,000 | -78.5% | 4,868 | -73.0% | 0.00% | – |
| Q4 2021 | $214,000 | +10600.0% | 18,059 | +8884.6% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 201 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -96.7% | 201 | -96.6% | 0.00% | – |
| Q1 2021 | $92,000 | -68.6% | 5,969 | -75.1% | 0.00% | – |
| Q4 2020 | $293,000 | +0.3% | 24,002 | +5.7% | 0.00% | – |
| Q3 2020 | $292,000 | – | 22,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |